Olema Pharmaceuticals, Inc. OLMA Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$162.45M-25.5% | -$129.47M-34.0% | -$96.66M+7.8% | -$104.79M-47.4% | ||
| $490K+24.7% | $393K+4.2% | $377K+5.6% | $357K+119% | ||
| $17.59M-22.1% | $22.58M+30.9% | $17.26M-8.4% | $18.83M+18.3% | ||
| -$146.72M-40.6% | -$104.35M-24.6% | -$83.73M-2.0% | -$82.07M-61.9% | ||
| —— | -$93.53M-1,828% | -$4.85M-105% | $91.48M— | ||
| $211.3M-21.4% | $268.82M+101% | $133.42M+27,928% | $476K— | ||
| —— | $70.94M— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Olema Pharmaceuticals, Inc. generate?
- Olema Pharmaceuticals, Inc. (OLMA) generated -$148.7M in operating cash flow over the trailing twelve months.
- What is Olema Pharmaceuticals, Inc.'s free cash flow?
- After $332.0K of capital expenditures, Olema Pharmaceuticals, Inc.'s free cash flow was -$115.4M over the trailing twelve months, down 30.9% year over year.
- Where does Olema Pharmaceuticals, Inc.'s cash flow data come from?
- Every line is extracted from Olema Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.